MNK-155, an extended-release hydrocodone/acetaminophen combination, shows efficacy in Phase 3 acute pain trial

Mallinckrodt has reported that a Phase 3 efficacy trial of investigational MNK-155 met the study's primary endpoint of improved pain scores vs.
Pain / Anesthetics News From Medical News Today

Share:

Related Content